Cellectar Biosciences (CLRB) Other Working Capital Changes (2010 - 2025)
Cellectar Biosciences (CLRB) posted Other Working Capital Changes of -$22343.0 for Q4 2025, down 3.54% sequentially from -$21580.0 in Q3 2025, and down 19.18% YoY from -$27646.0 in Q4 2024.
Cellectar Biosciences (CLRB) Other Working Capital Changes (2010 - 2025) Analysis & Trends
Cellectar Biosciences has reported Other Working Capital Changes for 12 years, with the latest figure at -$22343.0 in Q4 2025.
- Quarterly Other Working Capital Changes fell 19.18% year-over-year to -$22343.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$84417.0 (down 43.13% YoY) and the FY2025 annual result came in at -$84417.0, down 43.13% from the prior year.
- Other Working Capital Changes fell to -$22343.0 in Q4 2025 per CLRB's latest filing, from -$21580.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $701053.0 in Q3 2021 and troughed at -$746717.0 in Q2 2023.
- A 5-year average of $828.3 and a median of -$143831.0 in 2021 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes jumped 86.5% in 2023, then slumped 323.67% in 2025.
- Over 5 years, Other Working Capital Changes stood at -$31635.0 in 2021, then plunged by 39.92% to -$44263.0 in 2022, then soared by 63.78% to -$16031.0 in 2023, then decreased by 16.94% to -$18747.0 in 2024, then decreased by 19.18% to -$22343.0 in 2025.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$22343.0, -$21580.0, and -$20840.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Cellectar Biosciences | 6.75 Mn | 6.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -224,977.00 |
| Dec 31, 2025 | -224,977.00 |
| Dec 31, 2025 | -224,977.00 |
| Sep 30, 2025 | -509,170.00 |
| Sep 30, 2025 | -509,170.00 |
| Sep 30, 2025 | -509,170.00 |
| Jun 30, 2025 | 589,084.00 |
| Jun 30, 2025 | 589,084.00 |
| Jun 30, 2025 | 589,084.00 |
| Mar 31, 2025 | 25,830.00 |
| Mar 31, 2025 | 25,830.00 |
| Mar 31, 2025 | 25,830.00 |
| Dec 31, 2024 | -674,153.00 |
| Dec 31, 2024 | -674,153.00 |
| Dec 31, 2024 | -674,153.00 |
| Sep 30, 2024 | -400,635.00 |
| Sep 30, 2024 | -400,635.00 |
| Sep 30, 2024 | -400,635.00 |
| Jun 30, 2024 | 699,269.00 |
| Jun 30, 2024 | 699,269.00 |